FDA approves PIQRAY: First PI3K inhibitor tablet for breast cancer Deepanjana Sarkar28 May 2019 7:28 PM ISTThe US Food and Administration (FDA) has approved the first ever PI3K Inhibitor [Piqray (alpelisib)] oral tablets to treat postmenopausal women, and...
FDA approves novel antibody-drug conjugate for common non-Hodgkin lymphoma Hina Zahid11 Jun 2019 7:10 PM ISTFood and Drug Administration, FDA has approved novel antibody-drug conjugate for diffuse large B-cell lymphoma, a common type of on-Hodgkin...
Include men in clinical trials for breast cancer, stresses FDA in a draft guidance Medha Baranwal Baranwal27 Aug 2019 7:25 PM ISTUSA: The U.S. Food and Drug Administration has stressed the inclusion of male patients in the clinical trials of breast cancer, in a recently released...
FDA approves first therapy to reduce vaso-occlusive crisis in sickle cell disease Hina Zahid18 Nov 2019 7:30 PM ISTFDA has approved first therapy to reduce the frequency of vaso-occlusive crisis, a painful complication of sickle cell disease in patients above 16...
Oxbryta- New drug for Sickle cell disease receives FDA approval Hina Zahid26 Nov 2019 7:25 PM ISTU.S. Food and Drug Administration has granted accelerated approval to Oxbryta (voxelotor) for the treatment of sickle cell disease (SCD) in adults and...
FDA approves Enhertu for patients with HER2-positive breast cancer Hina Zahid22 Dec 2019 9:05 AM ISTU.S. Food and Drug Administration granted accelerated approval to Enhertu (fam-trastuzumab deruxtecan-nxki) for the treatment of adults with...
